Canopy Growth (CGC) Return on Capital Employed Growth (1y) (2021 - 2026)
Canopy Growth (CGC) Return on Capital Employed Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 333.00 |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -469.00 |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 8.00 |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 220.00 |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 802.00 |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 340.00 |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 573.00 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Canopy Growth | 445.49 Mn | 198.48 Mn | 16.08 Mn | -213.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 222.00 |
| Dec 31, 2025 | 637.00 |
| Sep 30, 2025 | 1,385.00 |
| Jun 30, 2025 | 357.00 |
| Dec 31, 2024 | 3,229.00 |
| Sep 30, 2024 | 1,554.00 |
| Jun 30, 2024 | 2,723.00 |
| Mar 31, 2024 | 12,401.00 |
| Dec 31, 2023 | 5,656.00 |
| Sep 30, 2023 | 5,055.00 |
| Jun 30, 2023 | 1,793.00 |
| Mar 31, 2023 | -12,928.00 |
| Dec 31, 2022 | -9,555.00 |
| Sep 30, 2022 | -7,433.00 |
| Jun 30, 2022 | -4,600.00 |
| Mar 31, 2022 | 153.00 |
| Dec 31, 2021 | 1,805.00 |
| Sep 30, 2021 | 814.00 |
| Jun 30, 2021 | 593.00 |
| Mar 31, 2021 | 3,364.00 |